RxDoctor Payments Data

Irina Dariychuk

Registered Nurse · Antelope, CANPI 1477871630

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $217,200 of the $242,283 with a category attached, or 89.6%. Every reported general payment came from a single manufacturer, AbbVie. Reporting peaked in 2023 at $113,804 and has fallen 52.6% since, to $53,950 in 2025. Among registered nurse clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$242,283in general payments, 2019–2025

Across 419 payments — averaging $578.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$242K

What the payments were for

  • Speaking & faculty fees$217,20090%
  • Travel & lodging$14,7326%
  • Food & beverage$10,3514%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)419$242,283

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$242,283 in reported general payments places this provider in the 95th percentile of 533 registered nurse providers in California.

See all registered nurse providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
ProgesteroneProgesterone, Micronized11$669

Paid to pharmacies, not to this prescriber.

Other registered nurse in Antelope

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →